Impaired coagulation in the bleeding of chronic liver disease.
作者信息
Losowsky M S
出版信息
J R Coll Physicians Lond. 1973 Oct;8(1):79-86.
Abstract
摘要
相似文献
1
Impaired coagulation in the bleeding of chronic liver disease.
J R Coll Physicians Lond. 1973 Oct;8(1):79-86.
2
Hemostasis.
Surg Annu. 1973;5:145-55.
3
Surgical bleeding.
Med Clin North Am. 1972 Jan;56(1):207-19. doi: 10.1016/s0025-7125(16)32436-1.
4
Evaluation and management of the bleeding patient.
Med Clin North Am. 1981 Jan;65(1):133-46. doi: 10.1016/s0025-7125(16)31544-9.
5
Coagulopathy in liver disease: a balancing act.
Hematology Am Soc Hematol Educ Program. 2015;2015:243-9. doi: 10.1182/asheducation-2015.1.243.
6
Bleeding disorders due to abnormal platelet function.
Med Clin North Am. 1973 Mar;57(2):517-30. doi: 10.1016/s0025-7125(16)32295-7.
7
[Hemostasis disorders in liver diseases].
Pol Tyg Lek. 1974 Jun;29(25):1097-100.
8
Blood clotting abnormalities in liver disease.
Prog Liver Dis. 1976;5:350-62.
9
Coagulation studies: prothrombin time, partial thromboplastin time, bleeding time.
Emerg Med Clin North Am. 1986 Feb;4(1):95-113.
10
Bleeding Risk and Management in Interventional Procedures in Chronic Liver Disease.
J Vasc Interv Radiol. 2016 Nov;27(11):1665-1674. doi: 10.1016/j.jvir.2016.05.039. Epub 2016 Aug 29.
本文引用的文献
1
The significance of the Hageman-factor for the effect of wettable surface on thrombocytes.
Thromb Diath Haemorrh. 1962 Mar 15;7:48-69.
2
EXCESSIVE CONSUMPTION OF BLOOD COAGULATION COMPONENTS AS CAUSE OF HEMORRHAGIC DIATHESIS.
Am J Med. 1965 Jun;38:899-908. doi: 10.1016/0002-9343(65)90009-4.
3
JAUNDICE AND ITS RELATION TO THERAPEUTIC AGENTS.
Lancet. 1965 Jan 23;1(7378):175-9. doi: 10.1016/s0140-6736(65)90969-4.
4
[THE PLATELET FACTOR IN ALCOHOLIC CIRRHOSIS. STUDY OF THEIR ADHESIVENESS IN VITRO BY THE BORCHGREVINK TEST].
Arch Mal Appar Dig Mal Nutr. 1964 Sep;53:1041-5.
5
ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.
J Clin Invest. 1964 Apr;43(4):681-95. doi: 10.1172/JCI104953.
6
STUDIES ON BLOOD COAGULATION FACTORS IN A CASE OF LIVER CIRRHOSIS. REMISSION OF THE HEMORRHAGIC TENDENCY ON TREATMENT WITH HEPARIN.
Acta Med Scand. 1964 Feb;175:177-83. doi: 10.1111/j.0954-6820.1964.tb00564.x.
7
STATISTICAL CORRELATION OF LIVER FUNCTION TESTS WITH COAGULATION FACTOR DEFICIENCIES IN LAENNEC'S CIRRHOSIS.
Thromb Diath Haemorrh. 1964 Jan 1;10:317-31.
8
CONTROL OF FIBRINOLYSIS DURING PORTACAVAL SHUNTS. STUDY OF PATIENTS WITH CIRRHOSIS OF THE LIVER.
JAMA. 1964 Mar 28;187:1005-8.
9
HOMOTRANSPLANTATION OF THE LIVER IN HUMANS.
Surg Gynecol Obstet. 1963 Dec;117:659-76.
10
Clotting tests and other tests of the haemostatic mechanism in cirrhosis of the liver and their diagnostic significance.
Acta Med Scand. 1962 Aug;172:229-35. doi: 10.1111/j.0954-6820.1962.tb07147.x.
Zotero 插件